Immatics (IMTX) Depreciation & Amortization (IS) (2019 - 2025)
Immatics recorded quarterly Depreciation & Amortization (IS) of $3.7 million in Q4 2025, up 2.95% quarter-over-quarter from $3.6 million in Q3 2025, and up 12.23% year-over-year from $3.3 million in Q4 2024.
Immatics' Depreciation & Amortization (IS) history runs 7 years deep, the most recent figure standing at $3.7 million for Q4 2025.
- In Q4 2025, Depreciation & Amortization (IS) rose 12.23% year-over-year to $3.7 million; the TTM figure through Dec 2025 stood at $14.0 million (up 5.8% YoY), while the FY2025 annual figure was $14.0 million, up 7.24% from the prior year.
- Depreciation & Amortization (IS) came in at $3.7 million for Q4 2025 at Immatics, up from $3.6 million in the prior quarter.
- In the past five years, Depreciation & Amortization (IS) ranged from a high of $3.7 million in Q4 2025 to a low of -$5.8 million in Q4 2023.
- A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Depreciation & Amortization (IS).
- Across the five-year window, Depreciation & Amortization (IS) slumped 427.09% in 2023 and soared 156.32% in 2024, its largest moves.
- Immatics' Depreciation & Amortization (IS) stood at $1.5 million in 2021, then grew by 20.64% to $1.8 million in 2022, then plunged by 427.09% to -$5.8 million in 2023, then jumped by 156.32% to $3.3 million in 2024, then increased by 12.23% to $3.7 million in 2025.
- According to Business Quant data, Depreciation & Amortization (IS) over the past three periods registered $3.7 million, $3.6 million, and $3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 127,436.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 12.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.69 Mn |
| Sep 30, 2025 | 3.58 Mn |
| Jun 30, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | -5.84 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 1.94 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Sep 30, 2021 | 2.01 Mn |
| Jun 30, 2021 | 1.41 Mn |
| Mar 31, 2021 | 1.32 Mn |
| Dec 31, 2020 | 1.14 Mn |
| Sep 30, 2020 | 1.38 Mn |
| Jun 30, 2020 | 1.37 Mn |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 989,217.00 |